Rare Anemia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) (NCT00171301) | Novartis Pharmaceuticals | 2005-06-01 |
Track Rare Anemia automatically
Every clearance here is in the API, with alerts when new ones post.